RNA m6A reader YTHDF2 facilitates precursor miR-126 maturation to promote acute myeloid leukemia progression

Deng, 2018, RNA N(6)-methyladenosine modification in cancers: current status and perspectives, Cell Res, 28, 507, 10.1038/s41422-018-0034-6 Huang, 2020, m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer, Cancer Cell, 37, 270, 10.1016/j.ccell.2020.02.004 Shi, 2019, Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers, Mol Cell, 74, 640, 10.1016/j.molcel.2019.04.025 Liu, 2014, A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation, Nat Chem Biol, 10, 93, 10.1038/nchembio.1432 Wang, 2016, Structural basis for cooperative function of Mettl3 and Mettl14 methyltransferases, Mol Cell, 63, 306, 10.1016/j.molcel.2016.05.041 Wen, 2018, Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal, Mol Cell, 69, 1028, 10.1016/j.molcel.2018.02.015 Yue, 2018, VIRMA mediates preferential m(6)A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation, Cell Discov, 4, 10, 10.1038/s41421-018-0019-0 Scholler, 2018, Interactions, localization, and phosphorylation of the m(6)A generating METTL3-METTL14-WTAP complex, RNA, 24, 499, 10.1261/rna.064063.117 Brown, 2016, Methyltransferase-like protein 16 binds the 3'-terminal triple helix of MALAT1 long noncoding RNA, Proc Natl Acad Sci U S A, 113, 14013, 10.1073/pnas.1614759113 Pendleton, 2017, The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention, Cell, 169, 824, 10.1016/j.cell.2017.05.003 Warda, 2017, Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs, EMBO Rep, 18, 2004, 10.15252/embr.201744940 Shima, 2017, S-adenosylmethionine synthesis is regulated by selective N(6)-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1, Cell Rep, 21, 3354, 10.1016/j.celrep.2017.11.092 Mendel, 2018, Methylation of structured RNA by the m(6)A writer METTL16 is essential for mouse embryonic development, Mol Cell, 71, 986, 10.1016/j.molcel.2018.08.004 Doxtader, 2018, Structural basis for regulation of METTL16, an S-adenosylmethionine homeostasis factor, Mol Cell, 71, 1001, 10.1016/j.molcel.2018.07.025 Su, 2022, METTL16 exerts an m(6)A-independent function to facilitate translation and tumorigenesis, Nat Cell Biol, 24, 205, 10.1038/s41556-021-00835-2 Ma, 2019, N(6-)Methyladenosine methyltransferase ZCCHC4 mediates ribosomal RNA methylation, Nat Chem Biol, 15, 88, 10.1038/s41589-018-0184-3 Su, 2018, R-2HG exhibits anti-tumor activity by targeting FTO/m(6)A/MYC/CEBPA signaling, Cell, 172, 90, 10.1016/j.cell.2017.11.031 Shen, 2020, RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia, Cell Stem Cell, 27, 64, 10.1016/j.stem.2020.04.009 Huang, 2018, Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation, Nat Cell Biol, 20, 285, 10.1038/s41556-018-0045-z Han, 2019, Anti-tumour immunity controlled through mRNA m(6)A methylation and YTHDF1 in dendritic cells, Nature, 566, 270, 10.1038/s41586-019-0916-x Wang, 2015, N(6)-methyladenosine modulates messenger RNA translation efficiency, Cell, 161, 1388, 10.1016/j.cell.2015.05.014 Shi, 2017, YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA, Cell Res, 27, 315, 10.1038/cr.2017.15 Wang, 2014, N6-methyladenosine-dependent regulation of messenger RNA stability, Nature, 505, 117, 10.1038/nature12730 Zhen, 2020, m(6)A reader: epitranscriptome target prediction and functional characterization of N (6)-methyladenosine (m(6)A) readers, Front Cell Dev Biol, 8, 741, 10.3389/fcell.2020.00741 Alarcon, 2015, HNRNPA2B1 is a mediator of m(6)a-dependent nuclear RNA processing events, Cell, 162, 1299, 10.1016/j.cell.2015.08.011 Liu, 2015, N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions, Nature, 518, 560, 10.1038/nature14234 Alarcon, 2015, N6-methyladenosine marks primary microRNAs for processing, Nature, 519, 482, 10.1038/nature14281 Patil, 2016, m(6)A RNA methylation promotes XIST-mediated transcriptional repression, Nature, 537, 369, 10.1038/nature19342 Gebert, 2019, Regulation of microRNA function in animals, Nat Rev Mol Cell Biol, 20, 21, 10.1038/s41580-018-0045-7 Yendamuri, 2009, The role of microRNA in human leukemia: a review, Leukemia, 23, 1257, 10.1038/leu.2008.382 Ha, 2014, Regulation of microRNA biogenesis, Nat Rev Mol Cell Biol, 15, 509, 10.1038/nrm3838 Wallace, 2017, MicroRNAs and acute myeloid leukemia: therapeutic implications and emerging concepts, Blood, 130, 1290, 10.1182/blood-2016-10-697698 Ivey, 2015, microRNAs as developmental regulators, Cold Spring Harbor Perspect Biol, 7, 10.1101/cshperspect.a008144 Cheng, 2013, MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10), J Biol Chem, 288, 13748, 10.1074/jbc.M112.381392 Rottiers, 2012, MicroRNAs in metabolism and metabolic disorders, Nat Rev Mol Cell Biol, 13, 239, 10.1038/nrm3313 Lechman, 2016, miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells, Cancer Cell, 29, 214, 10.1016/j.ccell.2015.12.011 Zhang, 2018, Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia, Nat Med, 24, 450, 10.1038/nm.4499 Chen, 2010, Leukaemogenesis: more than mutant genes, Nat Rev Cancer, 10, 23, 10.1038/nrc2765 Li, 2008, Distinct microRNA expression profiles in acute myeloid leukemia with common translocations, Proc Natl Acad Sci U S A, 105, 15535, 10.1073/pnas.0808266105 Mi, 2007, MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia, Proc Natl Acad Sci U S A, 104, 19971, 10.1073/pnas.0709313104 Jiang, 2016, Eradication of acute myeloid leukemia with FLT3 ligand-targeted miR-150 nanoparticles, Cancer Res, 76, 4470, 10.1158/0008-5472.CAN-15-2949 Li, 2012, miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia, Nat Commun, 3, 688, 10.1038/ncomms1681 Fletcher, 2022, microRNA expression in acute myeloid leukaemia: new targets for therapy?, EJHaem, 3, 596, 10.1002/jha2.441 Bhatnagar, 2021, Clinical applications of MicroRNAs in acute myeloid leukemia: a mini-review, Front Oncol, 11, 10.3389/fonc.2021.679022 Weng, 2018, METTL14 inhibits hematopoietic stem/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification, Cell Stem Cell, 22, 191, 10.1016/j.stem.2017.11.016 Paris, 2019, Targeting the RNA m(6)A reader YTHDF2 selectively compromises cancer stem cells in acute myeloid leukemia, Cell Stem Cell, 25, 137, 10.1016/j.stem.2019.03.021 Cheng, 2021, N(6)-Methyladenosine on mRNA facilitates a phase-separated nuclear body that suppresses myeloid leukemic differentiation, Cancer Cell, 39, 958, 10.1016/j.ccell.2021.04.017 Yankova, 2021, Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia, Nature, 593, 597, 10.1038/s41586-021-03536-w Vu, 2017, The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells, Nat Med, 23, 1369, 10.1038/nm.4416 Weng, 2019, RNA N (6)-methyladenosine modification in normal and malignant hematopoiesis, Adv Exp Med Biol, 1143, 75, 10.1007/978-981-13-7342-8_4 Qing, 2021, RNA modifications in hematopoietic malignancies: a new research frontier, Blood, 138, 637, 10.1182/blood.2019004263 Li, 2017, FTO plays an oncogenic role in acute myeloid leukemia as a N6-methyladenosine RNA demethylase, Cancer Cell, 31, 127, 10.1016/j.ccell.2016.11.017 Vu, 2017, The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells, Nat Med, 23, 1369, 10.1038/nm.4416 Barbieri, 2017, Promoter-bound METTL3 maintains myeloid leukaemia by m(6)A-dependent translation control, Nature, 552, 126, 10.1038/nature24678 Huang, 2019, Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia, Cancer Cell, 35, 677, 10.1016/j.ccell.2019.03.006 Wang, 2020, Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling Axis, Cell Stem Cell, 27, 81, 10.1016/j.stem.2020.04.001 Weng, 2022, The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia, Cancer Cell, 40, 1, 10.1016/j.ccell.2022.10.004 Li, 2018, Suppression of m(6)A reader Ythdf2 promotes hematopoietic stem cell expansion, Cell Res, 28, 904, 10.1038/s41422-018-0072-0 Wang, 2018, Loss of YTHDF2-mediated m(6)A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration, Cell Res, 28, 1035, 10.1038/s41422-018-0082-y Chen, 2021, YTHDF2 is a potential target of AML1/ETO-HIF1alpha loop-mediated cell proliferation in t(8;21) AML, Oncogene, 40, 3786, 10.1038/s41388-021-01818-1 Zhang, 2022, METTL3 suppresses neuropathic pain via modulating N6-methyladenosine-dependent primary miR-150 processing, Cell Death Dis, 8, 80, 10.1038/s41420-022-00880-2 Lechman, 2012, Attenuation of miR-126 activity expands HSC in vivo without exhaustion, Cell Stem Cell, 11, 799, 10.1016/j.stem.2012.09.001 de Leeuw, 2014, Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication, Cancer Res, 74, 2094, 10.1158/0008-5472.CAN-13-1733 Lechman, 2016, miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells, Cancer Cell, 29, 602, 10.1016/j.ccell.2016.03.015 Li, 2015, Overexpression and knockout of miR-126 both promote leukemogenesis, Blood, 126, 2005, 10.1182/blood-2015-04-639062 Zhang, 2021, Targeting miR-126 in inv(16) acute myeloid leukemia inhibits leukemia development and leukemia stem cell maintenance, Nat Commun, 12, 6154, 10.1038/s41467-021-26420-7 Zhang, 2021, Treatment-induced arteriolar revascularization and miR-126 enhancement in bone marrow niche protect leukemic stem cells in AML, J Hematol Oncol, 14, 122, 10.1186/s13045-021-01133-y Bagger, 2019, BloodSpot: a database of healthy and malignant haematopoiesis updated with purified and single cell mRNA sequencing profiles, Nucleic Acids Res, 47, D881, 10.1093/nar/gky1076 Haferlach, 2010, Clinical utility of microarray-based gene expression profiling in the diagnosis and subclassification of leukemia: report from the International Microarray Innovations in Leukemia Study Group, J Clin Oncol, 28, 2529, 10.1200/JCO.2009.23.4732 Caicedo, 2020, Overcoming barriers to early disease intervention, Nat Biotechnol, 38, 669, 10.1038/s41587-020-0550-z Li, 2014, starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data, Nucleic Acids Res, 42, D92, 10.1093/nar/gkt1248 Jiang, 2012, Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia, Cancer Cell, 22, 524, 10.1016/j.ccr.2012.08.028 Qing, 2021, R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/m6A/PFKP/LDHB axis, Mol Cell, 81, 922, 10.1016/j.molcel.2020.12.026 Ma, 2021, The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity, J Exp Med, 218, 10.1084/jem.20210279 Kozomara, 2019, miRBase: from microRNA sequences to function, Nucleic Acids Res, 47, D155, 10.1093/nar/gky1141 Forero, 2019, qPCR-based methods for expression analysis of miRNAs, Biotechniques, 67, 192, 10.2144/btn-2019-0065 Schmittgen, 2004, A high-throughput method to monitor the expression of microRNA precursors, Nucleic Acids Res, 32, e43, 10.1093/nar/gnh040 Su, 2020, Targeting FTO suppresses cancer stem cell maintenance and immune evasion, Cancer Cell, 38, 79, 10.1016/j.ccell.2020.04.017 Han, 2023, METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism, Cell Stem Cell, 30, 52, 10.1016/j.stem.2022.12.006 Krivtsov, 2006, Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9, Nature, 442, 818, 10.1038/nature04980 Wang, 2010, The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML, Science, 327, 1650, 10.1126/science.1186624 Cusan, 2018, LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPalpha-dependent enhancers in AML, Blood, 131, 1730, 10.1182/blood-2017-09-807024 Fong, 2015, BET inhibitor resistance emerges from leukaemia stem cells, Nature, 525, 538, 10.1038/nature14888 Rathert, 2015, Transcriptional plasticity promotes primary and acquired resistance to BET inhibition, Nature, 525, 543, 10.1038/nature14898 Ye, 2015, Hematopoietic differentiation is required for initiation of acute myeloid leukemia, Cell Stem Cell, 17, 611, 10.1016/j.stem.2015.08.011 Greenblatt, 2018, CARM1 is essential for myeloid leukemogenesis but dispensable for normal hematopoiesis, Cancer Cell, 34, 868, 10.1016/j.ccell.2018.10.009 Jiang, 2012, Blockade of miR-150 maturation by MLL-fusion/MYC/LIN-28 is required for MLL-associated leukemia, Cancer Cell, 22, 524, 10.1016/j.ccr.2012.08.028 Chen, 2013, miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia, Proc Natl Acad Sci U S A, 110, 11511, 10.1073/pnas.1310144110 Jiang, 2016, miR-22 has a potent anti-tumor role with therapeutic potential in acute myeloid leukemia, Nat Commun, 7, 10.1038/ncomms11452 Jiang, 2012, miR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia, Proc Natl Acad Sci USA, 109, 19397, 10.1073/pnas.1217519109 Weng, 2015, The pathological role and prognostic impact of miR-181 in acute myeloid leukemia, Cancer Genet, 208, 225, 10.1016/j.cancergen.2014.12.006 Youn, 2018, High-density proximity mapping reveals the subcellular organization of mRNA-associated granules and bodies, Mol Cell, 69, 517, 10.1016/j.molcel.2017.12.020 Döhner, 2015, Acute myeloid leukemia, N Engl J Med, 373, 1136, 10.1056/NEJMra1406184 Burnett, 2011, Therapeutic advances in acute myeloid leukemia, J Clin Oncol, 29, 487, 10.1200/JCO.2010.30.1820 Velasco-Hernandez, 2016, Potential pitfalls of the mx1-cre system: implications for experimental modeling of normal and malignant hematopoiesis, Stem Cell Rep, 7, 11, 10.1016/j.stemcr.2016.06.002 Healy, 2021, Recent progress in interferon therapy for myeloid malignancies, Front Oncol, 11, 10.3389/fonc.2021.769628 Yilmaz, 2008, The PI-3kinase pathway in hematopoietic stem cells and leukemia-initiating cells: a mechanistic difference between normal and cancer stem cells, Blood Cells Mol Dis, 41, 73, 10.1016/j.bcmd.2008.02.004 Erson-Bensan, 2017, m6A Modification and Implications for microRNAs, MicroRNA, 6, 97, 10.2174/2211536606666170511102219 Wang, 2019, N6-methyladenosine induced miR-143-3p promotes the brain metastasis of lung cancer via regulation of VASH1, Mol Cancer, 18, 181, 10.1186/s12943-019-1108-x Ma, 2017, METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6) -methyladenosine-dependent primary MicroRNA processing, Hepatology, 65, 529, 10.1002/hep.28885 Han, 2019, METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221/222 maturation in m6A-dependent manner, Mol Cancer, 18, 110, 10.1186/s12943-019-1036-9 Chen, 2021, N(6)-methyladenosine demethylase ALKBH5 suppresses malignancy of esophageal cancer by regulating microRNA biogenesis and RAI1 expression, Oncogene, 40, 5600, 10.1038/s41388-021-01966-4 Du, 2016, YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex, Nat Commun, 7, 10.1038/ncomms12626 Liu, 2012, Precursor microRNA-programmed silencing complex assembly pathways in mammals, Mol Cell, 46, 507, 10.1016/j.molcel.2012.03.010 Diederichs, 2007, Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression, Cell, 131, 1097, 10.1016/j.cell.2007.10.032 Jin, 2020, m(6)A demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC, Mol Cancer, 19, 40, 10.1186/s12943-020-01161-1 Frohn, 2012, Dicer-dependent and -independent Argonaute2 protein interaction networks in mammalian cells, Mol Cell Proteomics, 11, 1442, 10.1074/mcp.M112.017756